申请人:Merck Sharp & Dohme Ltd.
公开号:US05140034A1
公开(公告)日:1992-08-18
A class of 5-membered heterocyclic compounds having at least one heteroatom, substituted on the heterocyclic ring by an imidazolyl moiety, are useful in the treatment of psychotic disorders (e.g. schizophrenia and mania); anxiety; alcohol or drug withdrawal or dependence; pain; gastric stasis; gastric dysfunction (such as occurs with dyspepsia, peptic ulcer, reflux oesophagitis and flatulence); migraine, nausea and vomiting; movement disorders; and presenile and senile dementia.
一类具有至少一个杂原子的5元杂环化合物,其杂环环上被咪唑基取代,可用于治疗精神分裂症(如精神分裂症和狂躁症);焦虑;酒精或药物戒断或依赖;疼痛;胃潴留;胃功能障碍(如消化不良、消化性溃疡、反流性食管炎和胀气);偏头痛、恶心和呕吐;运动障碍;以及老年性痴呆症和老年性痴呆症。